Entrepreneurial Collaboration—Arbor Networks
In today's world, worm viruses, denial of service attacks, and other attacks on infrastructure make security a top concern. A solution came from the University of Michigan research lab of Dr. Farnam Jahanian, and the thesis work of his then-graduate student Dr. G. Robert Manlan. Today, with funding from Cisco Systems and Battery Ventures, they are the co-founders of Arbor Networks, named by UPSIDE Magazine as a Hot 100 Private Company, and by both RedHerring and Network World as one of Ten Start-Ups to Watch.
More information: http://www.techtransfer.umich.edu/stories/arbor.html

Health Collaboration—FluMist
The Centers for Disease Control and Prevention estimates that each year about 114,000 people in the United States are hospitalized and about 20,000 people die from influenza. Delivered as a nasal mist, FluMist could offer an important new approach to help protect people from influenza. FluMist is the only influenza vaccine delivered as a nasal mist to be commercially available in the U.S., and was invented by Hunein "John" Maassab, emeritus professor of epidemiology at the University of Michigan School of Public Health. A subsidiary of Medimmune Inc. will manufacture and market FluMist, and Wyeth Vaccines will co-market it.
More information: http://www.techtransfer.umich.edu/stories/flumist.html